Infliximab Delays but Does Not Avoid the Need for Surgery in Treatment-Resistant Pediatric Crohn’ Disease

Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial

Stephen B. Hanauer, Brian G. Feagan, Gary R. Lichtenstein et al. · The Lancet · 2002 · 4.2K citations

Veterinary Medicine, Immunology, Pharmacotherapy +12

A SIMPLE INDEX OF CROHN'S-DISEASE ACTIVITY

Richard F. Harvey, J.M. Bradshaw · The Lancet · 1980 · 3K citations

Medicine, Clinical Sciences, Internal Medicine +12

A Simple Classification of Crohnʼs Disease: Report of the Working Party for the World Congresses of Gastroenterology, Vienna 1998

Christoph Gasché, Jürgen Schölmerich, Geert D’Haens et al. · Inflammatory Bowel Diseases · 2000 · 1.1K citations · Full text

Medicine, Clinical Sciences, Internal Medicine +9

Efficacy and safety of retreatment with anti–tumor necrosis factor antibody (infliximab) to maintain remission in Crohn's disease

Paul Rutgeerts, Geert D’Haens, Stephan R. Targan et al. · Gastroenterology · 1999 · 1.1K citations · Full text

Life Sciences, Immunology, Pharmacotherapy +10

Tumor necrosis factor α-producing cells in the intestinal mucosa of children with inflammatory bowel disease

Emma J. Breese, Colin Michie, S. W. Nicholls et al. · Gastroenterology · 1994 · 575 citations

Life Sciences, Immunology, Pathology +16